Patents by Inventor Matthias Engel

Matthias Engel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240147674
    Abstract: A plug-in module. The plug-in module includes a module housing, a heat-dissipating device, and an electrical component arranged on a printed circuit board. The heat-dissipating device has, on a surface facing the electrical component, an internal thermal interface to thermally couple the electrical component to the heat-dissipating device. The heat-dissipating device has, on a surface facing away from the electrical component, an external thermal interface to thermally couple at least one heat-dissipating device to an external heat sink. The external thermal interface includes a thermally conductive elastic compensating element connected to the heat-dissipating device and designed to be compressed during formation of the external thermal interface.
    Type: Application
    Filed: March 29, 2022
    Publication date: May 2, 2024
    Inventors: Benedict Bonpain, Florian Burger, Manuel Maul, Matthias Engel, Roland Hellwig
  • Patent number: 11705623
    Abstract: A roof antenna for a vehicle has a cover that is connected to a baseplate via a latching unit. The latching unit comprises latching hooks that releasably engage behind elastic latching lugs.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: July 18, 2023
    Assignee: FUBA Automotive Electronics GmbH
    Inventors: Jürgen Sczesny, Matthias Engel
  • Publication number: 20220013886
    Abstract: A roof antenna for a vehicle has a cover that is connected to a baseplate via a latching unit. The latching unit comprises latching hooks that releasably engage behind elastic latching lugs.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 13, 2022
    Inventors: Jürgen Sczesny, Matthias Engel
  • Publication number: 20180228858
    Abstract: A plant extract, derived from a Salvia spp, may include one of at least one tanshinone compound, or at least one tanshinone compounds including a CYP11B1 inhibitory amount of at least one of tanshinone I and dihydrotanshinone. The plant extract may be used for use in the treatment of a wound or Cushing's syndrome.
    Type: Application
    Filed: November 30, 2015
    Publication date: August 16, 2018
    Inventors: Andrew B. Gallagher, Rolf W. Hartmann, Matthias Engel, Axel Koch, Chris J. Van Koppen
  • Patent number: 8912186
    Abstract: The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: December 16, 2014
    Assignee: Universitaet des Saarlandes
    Inventors: Matthias Engel, Wolfgang Fröhner, Adriane Stroba, Ricardo M. Biondi
  • Publication number: 20120046307
    Abstract: The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.
    Type: Application
    Filed: October 16, 2009
    Publication date: February 23, 2012
    Applicant: UNIVERSITAET DES SAARLANDES
    Inventors: Matthias Engel, Wolfgang Fröhner, Adriane Stroba, Ricardo M. Biondi
  • Publication number: 20070032474
    Abstract: The invention relates to a compound of formula I or pharmaceutically acceptable salts thereof. The invention further relates to methods of use of this compound.
    Type: Application
    Filed: June 10, 2004
    Publication date: February 8, 2007
    Inventors: Ricardo Biondi, Matthias Engel